Differential capacity of CD90+ cells in autophagy activation following chemotherapy in hepatocellular carcinoma.

Autor: Do, Huy Q., Luong, An B., Bonazza, Deborah, Bottin, Cristina, Doan, Thao P. T., Tran, Long D. C., Truong, Nhung H., Tell, Gianluca, Pham, Hoa L. T., Tiribelli, Claudio, Sukowati, Caecilia H. C.
Předmět:
Zdroj: Annals of Hepatology: Official Journal of the Mexican Association of Hepatology; Nov/Dec2020, Vol. 19 Issue 6, p645-652, 8p
Abstrakt: Introduction and Objectives. Analysis of cancer biomarkers is an important tool in developing targetedtherapy and in modulating chemoresistance. Here, we analyze the relevance of CD90, a marker of cancer stem cells (CSC) in hepatocellular carcinoma (HCC) and its correlation with autophagy. Materials and Methods. For in vivo study, 86 specimens were collected from 43 patients undergoing liver resections. In each patient, HCC nodule (HCC) and surrounding non-tumor (SNT) were collected. For in vitro study, HCC cells JHH6 subpopulations expressing CD90+ and CD90- were isolated using magnetic-sorter and confirmed by flow-cytometry. Upon doxorubicin treatment, autophagy turn-over was analyzed by RTqPCR for mRNA expression, Western blot for protein expression, and autophagosome staining for autophagyflux. Cytotoxicity test was performed by MTT assay. Gene and protein analysis were performed in clinical samples together with immunohistostaining. Results. CD90 mRNA expression was higher in HCC than in SNT for 8-fold (p < 0.001). LC3-II protein was up-regulated in the HCC in comparison with the SNT (p < 0.05). In vitro model showed that CD90+ and CD90- cells had diverse expressions of autophagyrelated genes. Upon doxorubicin treatment, autophagy was activated in both cells by increasing LC3-II protein expression, autophagic vacuoles, and dysregulation of autophagy-related mRNAs. A differential autophagic capacity was noticed between two subpopulations and it was correlated with cellular toxicity assay. Conclusions. We demonstrated the relevance of differential autophagy capacity of CD90+ cells in HCC. Autophagy was involved in cancer-defense mechanism against doxorubicin. Cancer promoting function of autophagy in CD90+ cells was also related to cancer environment. [ABSTRACT FROM AUTHOR]
Databáze: Complementary Index